chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pressure behind right eye, severe headache and hot flashes returned.    There was so much pressure behind my right eyeball that I thought my eyeball was going to pop out of the eye socket.  The pressure lasted for 2 full days.  Before the pressure it felt like someone was stabbing me with a nail in my right eye.   I rarely ever had a headache before the vaccine (maybe 1 mild one a year) and now I get headaches daily/  Hot flashes have returned and not gone away.  I hadn't had a hot flash in 10+ years and now they are back since taking the vaccine.
Vaccine administration provided to left deltoid at 8:20a.m.  While in recovering in the Obs area, patient complained of left arm heaviness, left chest pressure and dizziness. The patient was positioned in a wheelchair; during transport to the on site medical tent, the patient started passing out.  Prior to arriving at the Medical tent, the patient began flailing her arms, panicking and respiratory rate was observed to be a rate of about 60 breaths minute.  She was soothed and was observed to slow down her breathing and was subsequently transferred to a supine position on a stretcher.  She was provided water and a granola bar and EMS was summoned; Vital signs were 160/90, HR 76, SPo2 96% on room air. EMS  requested. The patient refused transport to the hospital; EMS assessed; BP was 138/88.  The patient stated that she felt better and refused transport to a local hospital.  She was continued to be observed; approx 5 minutes later she complained of visual blurring, a headache, and was observed to have a facial droop and word slurring.  Advised by EMS to be transported to hospital; she then agreed to transport to a local hospital.
Syncope with tonic-clonic arm movement, visual disturbance, fatigue. Patient was braced and came to after about 5-10 seconds. Was given water and cold compress and observed for 15 minutes. Patient reported feeling better sitting for the period of time.
giant line from left side of her forehead to her eyebrow; whole left side swollen/could not get rings off; whole left side swollen; headache that was like burst in left side of her head kind of like a cluster; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (whole left side swollen/could not get rings off), FACE OEDEMA (giant line from left side of her forehead to her eyebrow), CLUSTER HEADACHE (headache that was like burst in left side of her head kind of like a cluster) and SWELLING (whole left side swollen) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced CLUSTER HEADACHE (headache that was like burst in left side of her head kind of like a cluster). On 31-Mar-2021, the patient experienced PERIPHERAL SWELLING (whole left side swollen/could not get rings off) and SWELLING (whole left side swollen). On 01-Apr-2021, the patient experienced FACE OEDEMA (giant line from left side of her forehead to her eyebrow). At the time of the report, PERIPHERAL SWELLING (whole left side swollen/could not get rings off), FACE OEDEMA (giant line from left side of her forehead to her eyebrow), CLUSTER HEADACHE (headache that was like burst in left side of her head kind of like a cluster) and SWELLING (whole left side swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Hospitalization: 4/15/2023 - 4/20/2023 (5 days) Presentation to the ED: acute respiratory failure COVID + date: 4/20/2023 Treatment: Remdesivir  Discharge to: HOME.   006B21A 3/17/2021 037B21A 4/17/2021 046L21A 2/11/2022
?Covid arm?, on 9th day post vaccine, sit of injection became painful, swelled, red, hot to the touch. Symptoms slowly abated over a few days.
After H1N1 clinic at preschool, it was discovered that vaccine was given to 3 yr. old children that was for 4 yrs. and older. No immediate reaction noted.
Heart was fluttering after booster; Arm hurt after booster; Felt awful after booster; Stomach was burning after booster; Fever at 100.6 deg F after booster; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (Heart was fluttering after booster), PAIN IN EXTREMITY (Arm hurt after booster), VACCINATION COMPLICATION (Felt awful after booster), DYSPEPSIA (Stomach was burning after booster) and PYREXIA (Fever at 100.6 deg F after booster) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced CARDIAC FLUTTER (Heart was fluttering after booster), PAIN IN EXTREMITY (Arm hurt after booster), VACCINATION COMPLICATION (Felt awful after booster), DYSPEPSIA (Stomach was burning after booster) and PYREXIA (Fever at 100.6 deg F after booster). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse reaction, at a dose of 1 dosage form. At the time of the report, CARDIAC FLUTTER (Heart was fluttering after booster), PAIN IN EXTREMITY (Arm hurt after booster), VACCINATION COMPLICATION (Felt awful after booster), DYSPEPSIA (Stomach was burning after booster) and PYREXIA (Fever at 100.6 deg F after booster) outcome was unknown.            Company comment: This is a spontaneous case concerning a female patient of an unknown age with Breast cancer, who experienced the non-serious events cardiac flutter, fever and malaise. The events occurred after the third   dose of mRNA-1273. Patient describe "her heart felt funny" and "the heart is fluttering a little" that resolved spontaneously and not seek for medical care.   Concurrent  event pyrexia could be a potentially confounder for the heart flutter. The benefit-risk relationship of mRNA-1273 is not affected by this report.  No concomitant medications provided.   This case was linked to MOD-2021-402738, MOD-2021-402739 (Patient Link). Sender's Comments: This is a spontaneous case concerning a female patient of an unknown age with Breast cancer, who experienced the non-serious events cardiac flutter, fever and malaise. The events occurred after the third   dose of mRNA-1273. Patient describe "her heart felt funny" and "the heart is fluttering a little" that resolved spontaneously and not seek for medical care.   Concurrent  event pyrexia could be a potentially confounder for the heart flutter. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Information had been received on 20-APR-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient (age unknown) was inoculated with ZOSTAVAX on or about 18-APR-2014 at her pharmacy, as recommended for routine adult health maintenance for the prevention of shingles (dosage and lot#/expiration not reported). The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-SEP-2015, patient was treated at a medical facility for a painful rash that was diagnosed as shingles. While shingles is a chronic and incurable condition, patient has been prescribed acyclovir to manage her symptoms. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Rotavirus #1 given to patient w/ GERD and allergic colitis causing flare of colitis, symptoms persisted for months.
This spontaneous report as received from a registered pharmacist refers to a patient of unknown demographics. On unknown date, the patient was vaccinated with ZOSTAVAX (dosing details, route and lot number were not reported). No concomitant medications were reported. The pharmacist had a prescription for the second dose of ZOSTAVAX for a patient who previously on an unspecified date in September 2012 (reported as recently) had a prescription for ZOSTAVAX and the patient had enquired if a booster dose was recommended. The pharmacist had not spoken to the patient or the physician but was suspecting that the patient might have received improperly stored ZOSTAVAX or titer result was low or negative as the reason for second prescription. Additional information is not expected.
1/4/21 within 4 hours after receiving vaccine sole of right foot in the arch area began to itch.  Morning of 1/5/21 sole of left foot in arch area began to itch.  Upon a visual check a red rash is present approximately 1.5"-2" in diameter on the soles of both feet in the arch area.  1/6/21 blisters formed in rash area of the right foot.  On 1/8/21 upon patient visiting her dermatologist, the rash was ruled out as not being caused by a bacterial infection or fungal infection.  Dermatologist prescribed an antihistamine oral medication and a steroid cream. 1/9/21 patients reports burning and itching increased and she used a frozen foot roller to treat the burning and itching.  1/10/21 Patient states that itching and burning  subsided and discontinued use of steroid cream.   Patient continues to take oral antihistamine (Hydroxyzine HCL 25mg) prescribed by dermatologist . Patient reports there have been no changes in soaps or detergents being used and no changes in behavior prior to vaccination and therefore, patient and doctor can, but without certainty, conclude that the rash is a result of the COVID-19 vaccination.  1/11/21 patient took pictures of rash and are available for viewing.  As of 1/14/21 rash still present but itching has stopped. This event is a non-severe adverse event.  Patient is scheduled to receive second dose of vaccination on 1/25/21.  Patient has been advised to take antihistamine prior to receiving second dose of vaccination and  again 12 hours following the 2nd dose of vaccination.
Returned to office  two hours after immunization with generalized urticaria. Vital signs-normal, pulse ox 99. Given Benadryl and observed in office with good resolution. No respiratory symptoms. to continue with Atarax @ home
Immediately after vaccine within seconds, I became dizzy. Within about 4 minutes, I started vomiting. 12 minutes in, I had a seizure. I have a history with seizures, so the pharmacy dept. helped with me. I also had a fever for 2 weeks, mainly at nights. My temp got to 100.4 at the highest.
Pt received Janssen vaccine on 10/01/2021. Pt was diagnosed with COVID outpatient on 11/05/21. Pt presented to the ED on 11/06 with complaints of SOB and cough requiring supplemental oxygen. Pt was found to have COVID pneumonia. PT ended up being intubated due to respiratory failure. Pt expired on 11/13/2021.
Fever between 101 and 102.6 (highest temp taken before bed Sunday p.m.); severe headache, cough, severe muscle aches, pain in every joint, including my feet.  Today is 72 hours since the injection and I am extremely fatigued, although my fever is gone, and the muscle/joint pain is greatly reduced.
shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient was over the age of 65 and had a prior history of shingles outbreaks.  The patient received the first dose of Shingrix and experienced shingles and never went back for the second dose. This case is one of the 3 cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020153380:same reporter US-GLAXOSMITHKLINE-US2020153378:same reporter
15-20 minutes after giving immunization, developed urticaria, rash over the face. No difficult of breathing vx stable and Benadryl Im given.
having shortens of breath; cold  sweat; low temperature of 96.4°F; chills; felling  nauseas; body aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (having shortens of breath), COLD SWEAT (cold  sweat), CHILLS (chills), HYPOTHERMIA (low temperature of 96.4°F) and NAUSEA (felling  nauseas) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (having shortens of breath), COLD SWEAT (cold  sweat), CHILLS (chills), HYPOTHERMIA (low temperature of 96.4°F), NAUSEA (felling  nauseas) and MYALGIA (body aches). At the time of the report, DYSPNOEA (having shortens of breath), COLD SWEAT (cold  sweat), CHILLS (chills), HYPOTHERMIA (low temperature of 96.4°F), NAUSEA (felling  nauseas) and MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 96.4 (Low) 96.4 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment medications were not provided   Most recent FOLLOW-UP information incorporated above includes: On 25-Sep-2021: Significant follow-up received on 27-Sep: Reporter last name corrected to YUT. Event (body ache, cold sweat) added.
itching off and on all over her body, tingling here, tingling there; itching off and on all over her body, tingling here, tingling there; This is a spontaneous report from a contactable consumer(patient) or other non hcp. A 77-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection with Batch/Lot Number: EW0150; Expiration Date: 30Jul2021), via an unspecified route of administration, administered in Arm Left on 01Apr2021 09:30 (at the age of 77-year) as dose 1, single for COVID-19 immunisation. Medical history included ongoing non-alcoholic fatty liver disease, ongoing diabetes mellitus, COVID-19 (She says she did have COVID, that was a long story, she had several hospitalizations, she thinks it was before 22Dec2020 but seemed like the effects were there for a while. She says her doctor did not have her tested for it until her isolation ended 26Jan2021 and that the COVID was about 3 weeks before that), breast cancer, mastectomy, perforated bowl, ileostomy and lost about 50 pounds. Family medical history included that her father died of brain cancer. Concomitant medication(s) included anastrozole (ANASTROZOLE) taken for chemotherapy, start and stop date were not reported; metformin (METFORMIN) taken for diabetes mellitus, start and stop date were not reported; glibenclamide (GLYBURIDE) taken for diabetes mellitus, start and stop date were not reported. The patient experienced itching off and on all over her body, tingling here, tingling there on 06Apr2021. It was reported that the patient missed second dose on 27Apr2021. She says she did have an ultrasound yesterday for the liver and has an upcoming appointment on 27Apr2021. She asks should she postpone her vaccine shot until she has had her liver specialty doctor check her out. The patient underwent lab tests and procedures which included ultrasound liver with no result on 14Apr2021, weight lost about 50 pounds, weight gained some of it back but not all of it on an unspecified date. The patient did not visited to emergency room/ physician office due to events. The events outcome for itching off and on all over her body, tingling here, tingling there on was reported as recovering.  No follow-up attempts are needed. No further information is expected.
difficult to get up; very cold; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (difficult to get up), NASOPHARYNGITIS (very cold) and HEADACHE (headache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced NASOPHARYNGITIS (very cold) and HEADACHE (headache). On 29-Apr-2021, the patient experienced DYSSTASIA (difficult to get up). At the time of the report, DYSSTASIA (difficult to get up), NASOPHARYNGITIS (very cold) and HEADACHE (headache) outcome was unknown.            This case was linked to MOD-2021-098979 (Patient Link).
Right deltoid reaction - red and swollen - hot. pain down the arm. treated with antibiotics for cellulitis.
Flu and Pneumonia vaccine given in same syringe. Currently in process of re-vaccinating per CDC.
1st night very out of breath. O2 at 93 on sensor at home.  Felt better next day.  3/29/21 - went to ER for blood clot in left leg.
Patient fainted and quickly recovered. The fainting spell lasted approximately 15 seconds. Patient was monitored for 20 minutes after fainting spell occurred. No further incidents were monitored during that time.
Generalized red, vesicul0papular rash, otherwise, asymptomatic.
Redness, pain at injection site 24 hrs after MMRV given persisted for 6 days.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 08-OCT-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1512 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
2nd dose given 20 days after 1st; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 18-year-old female patient who received HBV (Engerix B) (batch number 25K3M, expiry date 02-JUN-2024) for prophylaxis.   Concomitant products included HEPATITIS B VACCINE (ENGERIX B).   On 11-APR-2023, the patient received the 2nd dose of Engerix B. On 11-APR-2023, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too short (Verbatim: 2nd dose given 20 days after 1st). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 13-APR-2023 The reporter informed that a patient received the 2nd dose of Engerix B 20 days after the first dose. The patient received 2nd dose of Engerix B earlier than the recommended interval, which led to shortening of vaccinations schedule.  Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.
1st dose 1 year ago/ restart series; This case was reported by a other health professional via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 1 year ago from the date of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-NOV-2022 Reporter's comment: The reporter would like information on if patient should restart series after 1 year of the 1st dose. No further information available.  The reporter consented to follow-up. Additional Supportive Information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to Incomplete course of vaccination.
On the morning of January 20th, I developed extreme tightening sensation in my chest. My right arm went tingly and then numb. I sat down for a few minutes and when I stood up my left arm went tingly and numb. I then broke out in a cold sweat and then started having difficulty breathing. I called EMS and was rushed to the ER in cardiac distress. I was given aspirin, nitro, and blood thinner in the ambulance and ER. The pain and symptoms were the worst in the ambulance which was roughly 30 minute after the onset of symptoms. After it was established I was not having a heart attack, they determined I had Myocarditis. I was admitted to the hospital and stayed overnight and was discharged around 7:30pm on January 21st.
About 16 hours later I woke up in a cold sweat with a very high fever and shivering. My body ached all over and I had a horrible headache and massive fatigue that is still lingering. All the symptoms lasted for 2 days but then started to dissipate. I was left feeling incredibly weak and lethargic. I still have the same brain fog, aches and fatigue nearly 4 weeks later.  However, now it's even worse after I got my second shot yesterday (9/30/2021 at 10:30 am).   Last night i once again woke up to a fever, sweating, shivering, aches and massive headache/migraine and fatigue.  I am typing this from my laptop in bed. These shots are the worst decision I ever made. I feel horrible - to the point that I'm concerned the vaccination has done permanent damage to me.
The pt immediately experienced pain, 2-4" edema and redness with swelling. This lasted 4 days. Was still red for 2 weeks.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 63-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 as dose 1, single (Batch/Lot number: unknown) and on 18Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 62 years for covid-19 immunisation; coviD-19 vaccine mRNA (mRNA 1273) (MODERNA COVID-19 VACCINE), on 31Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 10Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No other Medication in 2 weeks. Past drug history included: Dilantin, reaction(s): "Known allergies: Dilantin", notes: Known allergies: Dilantin; Acetaminophen, reaction(s): "Known allergies: Acetaminophen", notes: Known allergies: Acetaminophen; Pseudoephedrine, reaction(s): "Known allergies: Pseudoephedrine", notes: Known allergies: Pseudoephedrine. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04Aug2022) Negative, notes: Tested negative on Day 8 with few symptoms; (05Aug2022) Positive, notes: Tested positive on Day 9 with recurrence of symptoms. Therapeutic measures were taken as a result of vaccination failure, covid-19 included Paxlovid from 28Jul2022 to 02Aug2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.